The emerging field of psychedelics offers significant potential for therapeutic applications but also presents complex regulatory challenges. At Asebey Life Science Law, we provide comprehensive legal guidance to clients navigating the evolving landscape of psychedelic substances. Our expertise spans regulatory compliance, clinical trials, and strategic business support, ensuring our clients can innovate safely and effectively within this burgeoning industry. We are dedicated to helping clients understand the legal intricacies and capitalize on new opportunities in the psychedelics sector.
Psychedelics
Select Publications
Regulatory Law & the Psychedelic Renaissance, Edgar J. Asebey, Esq. and James T. O’Reilly, Esq., PLI Chronicle: Insights and Perspectives for the Legal Community, Nov./Dec. 2023
Regulatory Compliance
Regulatory Compliance
Decades of combined experience in the biotechnology sector, which translates directly to the needs of psychedelic biotech companies.
Business Transactions
Business Transactions
We guide our clients through the intricacies of these transactions, helping them thrive in a rapidly evolving market.
DEA Licenses
DEA Licenses
Our expertise guides clients through the application process, ensuring compliance with all regulatory requirements.
Clinical trials
Clinical trials
We support our clients through every phase of the clinical trial process, from protocol development to post-trial analysis.
Capital Raise & Venture Finance
Capital Raise & Venture Finance
We help clients articulate their value proposition, navigate due diligence processes, and execute financial transactions.